Matches in Wikidata for { <http://www.wikidata.org/entity/Q85895522> ?p ?o ?g. }
- Q85895522 description "2014 nî lūn-bûn" @default.
- Q85895522 description "2014年の論文" @default.
- Q85895522 description "2014年学术文章" @default.
- Q85895522 description "2014年学术文章" @default.
- Q85895522 description "2014年学术文章" @default.
- Q85895522 description "2014年学术文章" @default.
- Q85895522 description "2014年学术文章" @default.
- Q85895522 description "2014年学术文章" @default.
- Q85895522 description "2014年學術文章" @default.
- Q85895522 description "2014年學術文章" @default.
- Q85895522 description "2014年學術文章" @default.
- Q85895522 description "2014年學術文章" @default.
- Q85895522 description "2014年學術文章" @default.
- Q85895522 description "2014년 논문" @default.
- Q85895522 description "article científic" @default.
- Q85895522 description "article scientific" @default.
- Q85895522 description "article scientifique" @default.
- Q85895522 description "articol științific" @default.
- Q85895522 description "articolo scientifico" @default.
- Q85895522 description "artigo científico" @default.
- Q85895522 description "artigo científico" @default.
- Q85895522 description "artigo científico" @default.
- Q85895522 description "artikel ilmiah" @default.
- Q85895522 description "artikull shkencor" @default.
- Q85895522 description "artikulong pang-agham" @default.
- Q85895522 description "artykuł naukowy" @default.
- Q85895522 description "artículo científico publicado en 2014" @default.
- Q85895522 description "artículu científicu" @default.
- Q85895522 description "bilimsel makale" @default.
- Q85895522 description "bài báo khoa học" @default.
- Q85895522 description "naučni članak" @default.
- Q85895522 description "scienca artikolo" @default.
- Q85895522 description "scientific article published on 30 October 2014" @default.
- Q85895522 description "scientific article published on 30 October 2014" @default.
- Q85895522 description "scientific article published on 30 October 2014" @default.
- Q85895522 description "teaduslik artikkel" @default.
- Q85895522 description "tieteellinen artikkeli" @default.
- Q85895522 description "tudományos cikk" @default.
- Q85895522 description "vedecký článok" @default.
- Q85895522 description "vetenskaplig artikel" @default.
- Q85895522 description "videnskabelig artikel udgivet 30. oktober 2014" @default.
- Q85895522 description "vitenskapelig artikkel" @default.
- Q85895522 description "vitskapeleg artikkel" @default.
- Q85895522 description "vědecký článek" @default.
- Q85895522 description "wetenschappelijk artikel" @default.
- Q85895522 description "wissenschaftlicher Artikel" @default.
- Q85895522 description "επιστημονικό άρθρο" @default.
- Q85895522 description "мақолаи илмӣ" @default.
- Q85895522 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q85895522 description "научна статия" @default.
- Q85895522 description "научная статья" @default.
- Q85895522 description "научни чланак" @default.
- Q85895522 description "научни чланак" @default.
- Q85895522 description "מאמר מדעי" @default.
- Q85895522 description "مقالة علمية نشرت في 30 أكتوبر 2014" @default.
- Q85895522 description "৩০ অক্টোবর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q85895522 description "บทความทางวิทยาศาสตร์" @default.
- Q85895522 description "სამეცნიერო სტატია" @default.
- Q85895522 name "90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas" @default.
- Q85895522 name "90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas" @default.
- Q85895522 type Item @default.
- Q85895522 label "90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas" @default.
- Q85895522 label "90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas" @default.
- Q85895522 prefLabel "90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas" @default.
- Q85895522 prefLabel "90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas" @default.
- Q85895522 P1433 Q85895522-27BDAF0C-4817-446F-9D7D-124F36AFACA6 @default.
- Q85895522 P1476 Q85895522-95E2F454-C68B-4FF2-A867-F0D1218166C3 @default.
- Q85895522 P2093 Q85895522-02ADB12F-DD07-4B47-90D2-0F3EC1D161CC @default.
- Q85895522 P2093 Q85895522-12142D1A-B32E-456C-BFC8-9E9D7891741F @default.
- Q85895522 P2093 Q85895522-2030FFD7-4131-4953-B987-13781F4B47BF @default.
- Q85895522 P2093 Q85895522-5C6ECEA6-381D-47F0-9AF2-C0BB7F3249A8 @default.
- Q85895522 P2093 Q85895522-5F66CFB6-3C89-4D34-BE91-0B986D99407C @default.
- Q85895522 P2093 Q85895522-6CBB1A11-9AB0-4494-BDE5-434ABB5D0C90 @default.
- Q85895522 P2093 Q85895522-7B7DBED9-6460-43A9-8C02-03935024FDC6 @default.
- Q85895522 P2093 Q85895522-8A2B8FD5-2D09-458B-8E29-64ABB93AEE25 @default.
- Q85895522 P2093 Q85895522-9A12A7B3-8151-45BF-88B1-28E0792EAA64 @default.
- Q85895522 P2093 Q85895522-B4578372-FA88-499D-AD7C-9425A23006CF @default.
- Q85895522 P2093 Q85895522-CF0F6AE2-8B44-4BFA-84E9-A70E1DA03ED4 @default.
- Q85895522 P2093 Q85895522-D06D8746-5A03-45E4-AC7B-B965BF854C68 @default.
- Q85895522 P304 Q85895522-CE62D753-4E96-496C-BE64-E8D3FF3E3EE1 @default.
- Q85895522 P31 Q85895522-7DC5400B-726D-49CC-88BD-84CD55C30313 @default.
- Q85895522 P356 Q85895522-7CDBB6DE-59C9-4A3F-A635-F851919CF3AA @default.
- Q85895522 P433 Q85895522-4F3C95C5-B1C7-4644-A98D-B22A69F9AF7C @default.
- Q85895522 P478 Q85895522-E8F48C6F-B73B-46A0-834F-54590A6B52AE @default.
- Q85895522 P50 Q85895522-69B27ED7-C15D-4486-AB24-83901ECE41A8 @default.
- Q85895522 P50 Q85895522-96244F2B-24EB-4430-A01A-B9FC4E0787BF @default.
- Q85895522 P577 Q85895522-45707570-0C13-4FEE-A674-73CB67723CBA @default.
- Q85895522 P698 Q85895522-08EC35B7-A6D4-4DE4-A838-5C84EFB586F6 @default.
- Q85895522 P356 MDU503 @default.
- Q85895522 P698 25361987 @default.
- Q85895522 P1433 Q326122 @default.
- Q85895522 P1476 "90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas" @default.
- Q85895522 P2093 "D Blaise" @default.
- Q85895522 P2093 "J Asselineau" @default.
- Q85895522 P2093 "K Bouabdallah" @default.
- Q85895522 P2093 "M Mohty" @default.
- Q85895522 P2093 "O Tournilhac" @default.
- Q85895522 P2093 "P Ceballos" @default.
- Q85895522 P2093 "P Chevalier" @default.
- Q85895522 P2093 "R Bouabdallah" @default.